Friday, 15 November 2019
Thursday, 14 November 2019
Breaking #Cannabis #Stock News -Isracann Biosciences (CSE: $IPOT.C) Hires Expert Consultancy LinC to Steer Israeli Cannabis Project
Breaking #Cannabis #Stock News
-Isracann Biosciences (CSE: $IPOT.C) Hires Expert Consultancy LinC to Steer
Israeli Cannabis Project
Expert Agronomic and Project
Management Knowledge Vital to Early Success
VANCOUVER,
BC, November 14, 2019 ( Investorideas.com Newswire ) – Isracann Biosciences Inc.
(CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company
focused on becoming a premier low cost, high quality cannabis producer for both
domestic and European export sales, has engaged the services of LinC by Growing
Smart Ltd. to deliver a formal project characterization roadmap for the
successful development of its proposed 230,000 sq. ft. purpose-built production
facility.
The
project characterization, is an in depth and detailed document profiling the
site-specific seasonal climatic conditions, including daily hours of sun,
average daily/nightly high and low temperatures, daily humidity levels, and UV
index levels. With that information, the project characterization determines
necessary greenhouse environmental controls and equipment for dehumidification,
air circulation, shading screens, active heating, cooling and carbon dioxide
enrichment.
LinC
is the cannabis specific arm of Grow Smart Ltd, with offices in Tel Aviv,
Israel and Shanghai, China. The company is an international agricultural
project management company supplying turnkey projects for the cannabis sector
delivering individually tailored solutions to the unique needs of each project.
In
addition to developing the project characterization for Isracann, LinC has been
contracted to provide site-specific cannabis agronomic services. Leading LinC’s
agronomics team is Tal Saadon, who holds a Master of Science in Agronomy with
over 10 years of commercial agriculture experience, primarily in greenhouse
cannabis cultivation from seed, harvest and drying processes through to extensive
experience working with multiple growers and the various arms of the Ministry
of Health. The team also includes second generation farmer Tal Tregerman, who
comes from a core founding family of an important agricultural Moshav (co-op
agri-community) in the prolific Negev region. Tregerman originally established
IMC Ltd., one of the first successful outdoor cannabis greenhouses in Israel
and firmly established his ability to develop farm concepts into successful
active operations.
LinC’s
team collaborates across the industry by working with growers, entrepreneurs,
investors, agricultural research centers, agricultural technology and input
companies alike. These efforts translate into over 20 years direct experience successfully
serving the medical cannabis industry in Israel and abroad. The company’s role
extends well beyond the initial planning phase by providing technical,
business, construction and financial solutions as well as ongoing knowledge
transfer and support throughout the entire lifecycle of Isracann’s production
facility.
Company
CEO Darryl Jones comments, “When we initially undertook this project, we knew
we would need to bring onboard a quality team with the knowledge and experience
to achieve timely results. LinC is that team, and we are very appreciative that
they were amenable to working with us. We know they have a long list of
potential projects available to them and we have worked long and hard to ensure
we are a priority with what is expected in the coming months. Their enthusiasm
for our project has been highly motivational to everyone concerned and we look
forward to implementing their detailed approach to developing what we
collectively believe will be one of the most efficient, highest-quality and
lowest cost licensed export production facilities throughout the entire
region.”
ON
BEHALF OF THE BOARD OF DIRECTORS
“Darryl Jones”
Darryl Jones
Chief
Executive Officer and President
About
Isracann Biosciences Inc. (CSE: IPOT) (XFRA:
A2PT0E) (OTC: ATLED)
Isracann is an Israeli-based cannabis company
focused on becoming a premier cannabis producer offering low-cost production targeting
undersupplied, major European marketplaces. Based in Israel's agricultural
sector, Isracann will leverage its development within the most experienced
country in the world with respect to cannabis research. The Company has secured agreements within Israel for
medicinal marijuana cultivation. For more information visit: www.isracann.com.
All statements,
other than statements of historical fact, included herein are forward-looking
statements that involve various risks and uncertainties. There can be no assurance
that such statements will prove to be accurate and actual results and future
events could differ materially from those anticipated in such statements.
Important factors that could cause actual results to differ, materially from
the Company’s expectations are disclosed in the Company’s documents filed from
time to time with the Canadian Securities Exchange, the British Columbia
Securities Commission, the Ontario Securities Commission, and the Alberta
Securities Commission.
Contact
Investor
Relations
Toll
Free: +1 855.205.0226
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure : this news release featuring CSE: IPOT is a paid for
news release on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
#Cannabis #Stocks (OTC: $RLBD) (NYSE: $APHA) (NYSE: $CGC) (NASDAQ: $NEPT) - Real Power of Brands in the Cannabis /#CBD Market
#Cannabis #Stocks (OTC:
$RLBD) (NYSE: $APHA) (NYSE:
$CGC) (NASDAQ: $NEPT) - Real Power of Brands in the Cannabis /#CBD Market
Point
Roberts WA, Delta, BC – November 14, 2019 - Investorideas.com, a
leading investor news resource covering cannabis and hemp stocks releases a
sector snapshot featuring Real Brands,
Inc. (OTC:RLBD),
reporting on the increased focus towards branding as both the CBD and cannabis
industries mature across North America.
Cannabis
and CBD products are becoming more socially accepted and consumer awareness
regarding these products continues to grow, which is making many companies
focus more on brand building with their current product offerings, with one of
the key market drivers being quality and consistency.
Read this in full
at https://www.investorideas.com/news/2019/cannabis/11141CBDMarket-RLBD-APHA-CGC-NEPT.asp
In
recent
news, “the US Cannabidiol (CBD) market is expected to rise
significantly during the period 2019-2023. The market is expected to be driven
by various growth enhancing factors such as aging population, growing use of
CBD among millennials, increasing prevalence of arthritis, removal of hemp from
Controlled Substance Act, etc.”
Nielsen
predicts that,
“By 2025, the U.S. hemp-derived CBD market could be a $6 billion industry when
considering legalized sales of food and beverage products containing CBD from
hemp.”
Real Brands, Inc. (OTC:RLBD), a
leading brand building company in the
legal Hemp-Derived CBD consumer products category, is targeting CBD categories
including: ingestibles, edibles and topicals.
The Company recently announced signing
a Letter of Intent with Wonder Labs, LLC to create a joint venture to leverage
Real Brands brand building and sales capabilities with Wonder Labs product
development and production capabilities. The joint venture will focus on
accelerating development of innovative hemp derived CBD and other unique
high-value consumer products and launching these products online and through
traditional retail channels.
“As we prepare to launch our
HempAid®, Humboldt Brands®, Omegahemp™ and CBD Pharmacy™ brands, we have
identified areas where we might benefit from additional resources,” said Real
Brands CEO, Jerry Pearring. “By combining certain of Real Brands resources with
Wonder Labs, we expect both parties will benefit from the other parties
distinct strengths while creating a joint venture that is broader in scope than
either company individually,” said Pearring.
“As the hemp derived CBD consumer
products marketplace evolves, new product innovation and speed to market are
becoming increasingly important,” commented Wonder Labs CEO Vicky Arbelaez-Scoates. “We believe this joint venture not only
enhances our efforts in these areas, but it also favorably impacts multiple other
aspects of our existing operations as well.”
Real Brands will have a controlling
interest in the joint venture while assuming and performing all management and
operational functions of the joint venture.
In addition, Wonder Labs will initially contribute a new consumer
product brand with innovative formulas while overseeing production of all
products developed and launched by the joint venture through its affiliated
owned and operated GMP and FDA certified manufacturing facility.
This
follows the company closing its
previously announced acquisition of the proprietary CBD formulas from
Integrative Medicine US of Coral Springs, Florida. The formulas consist of
Ancient Chinese and other Ancient Herbal Remedies that are paired with the
latest scientific breakthroughs in endocannabinoid systems, nutrients and hemp
derived CBD.
Acquiring and
Developing Consumer Product brands infused with Hemp-Derived CBD,
Developing an
E-commerce website, developing a tradition mass market distribution, developing
local, regional and national retail relationships and partnering with
innovative and strategic companies involved with Hemp-Derived CBD.”
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) has been seeing some successes with their cannabis
brands in the Canadian market having recently
announced that all five of its medical and recreational brands,
as well as its subsidiary, Broken Coast Cannabis' Head Grower were recognized
at the 6th Annual Canadian Cannabis Awards presented by Lift &
C.
The
Company received a total of seven awards. An expert panel of judges awarded
Broken Coast's Head Grower, Kevin Anderson 'Master Grower' and Aphria's Solei's
CBN Renew oil, 'Innovation of the Year'. Additionally, after more than 31,000
Canadians voted, the Company's adult-use brands Solei, RIFF, Good Supply, Broken
Coast, and its medical brand Aphria, took home top honours in product
categories.
"We
are thrilled to have not only all five of our brands across our medical and
recreational portfolios – Solei, RIFF, Good Supply, Broken Coast and Aphria –
recognized by thousands of Canadians but to have our Solei Renew CBN oil win
'Innovation of the Year'," said Irwin D. Simon, Interim CEO of Aphria.
"These awards speak to the quality of our products and strength of our
brands, as well as our commitment to innovation and continuously setting the
bar higher to deliver products we believe meet the needs of our patients and
consumers."
"We
are proud to see the hard work of Kevin Anderson, Head Grower at Broken Coast
honored," added Simon. "Broken Coast's superior craft quality is just
one reason why it continues to receive accolades and remains one of the most
sought-after brands on the market; another key factor is Kevin's expertise,
leadership and direction. We congratulate Kevin, and the teams in British
Columbia and Ontario for the award-winning work they continue to deliver.
Aphria's success will continue to be driven by our incredible employees, and
compelling and differentiated portfolio of brands and products."
Canopy Growth
Corporation (TSX:
WEED) (NYSE:
CGC)
and Aubrey Drake Graham ("Drake") recently
announced that they have entered into agreements to launch the
More Life Growth CompanyTM, a fully licensed producer of cannabis,
based in Drake's hometown of Toronto, Canada.
"When
we first began talks with Drake we were extremely inspired by and aligned with
his vision to bring best-in-class cannabis products to the world," said
Mark Zekulin, CEO of Canopy Growth Corporation. "Drake's perspective as a
culture leader and entrepreneur combined with Canopy Growth's breadth of
cannabis knowledge will allow our new company to bring an unmatched cannabis
experience to global markets."
Drake's
eclectic career includes experience across a wide variety of industries
including music, television, film, fashion, sports, brand development, content
curation and social and digital media strategy. Having launched numerous
successful brands over the past decade, he is uniquely positioned to bring his
innovative eye to the recreational cannabis industry.
"The
opportunity to partner with a world-class company like Canopy Growth on a
global scale is really exciting," shared More Life Growth Company founder,
Drake. "The idea of being able to build something special in an industry
that is ever growing has been inspiring. “More Life and More Blessing."
Proudly
based in Drake's hometown of Toronto, Ontario, More LifeTM is
centered around wellness, discovery and overall personal growth with the hope
of facilitating connections and shared experiences across the globe.
"All
in all, we couldn't be more excited to partner with Drake to bring his vision
for the More Life Growth Company to global cannabis markets," concluded
Mr. Zekulin. "We anticipate a long, successful, and mutually beneficial
working relationship."
The
Company and Drake will share further details on the More LifeTM team
and vision in the weeks to come.
Neptune Wellness
Solutions Inc. (NASDAQ:
NEPT) (TSX:
NEPT), a health and wellness company focused on extraction,
purification and formulation of cannabinoids, announced that it
has entered into a collaboration agreement with International Flavors & Fragrances Inc. to co-develop
hemp-derived CBD products for the mass retail and health & wellness
markets. App Connect Service, Inc. is also a party to the agreement to provide
related branding strategies and promotional activities.
Under
this strategic product development partnership, IFF will leverage its
intellectual property (IP) for taste, scent and nutrition to provide essential
oils and product development resources. Neptune will leverage its proprietary
cold ethanol extraction processes and formulation IP to deliver high quality,
full- and broad-spectrum extracts for the development, manufacture and
commercialization of hemp-derived products, infused with essential oils, for
the cosmetics, personal care and home care markets.
The
first products are expected to launch under Neptune's Forest Remedies brand at
US retailers in the first half of calendar 2020. The Initial launch will
include a variety of topical products across the aromatherapy category, a
market estimated at approximately $3 billion annually. Additional category
launches should follow and the total SKU count could ultimately exceed 50 SKUs.
Neptune will be responsible for the marketing and sale of the products. Neptune
will record revenues from product sales and in turn will pay a royalty to each
of IFF and App Connect associated with the sales of co-developed products.
"The
agreement represents a significant event in the development of our global
cannabis business, expanding our business model from primarily B2B to include a
robust B2C business platform. IFF has an impressive track record, remarkable
capabilities and global reach. This partnership will accelerate Neptune's
vision and growth strategy to be the leading producer of hemp extracts
ingredients and finished products for the global health & wellness and
Consumer Packaged Goods industries. We are also now better positioned to
leverage our management's experience building brands and relationships with key
North American retailers," stated Michael Cammarata, CEO of Neptune.
"We
are pleased to enter this strategic partnership and drive innovation that
satisfies customers' demands for quality, sustainability and
traceability," said Nicolas Mirzayantz, Divisional CEO, Scent at IFF.
"The hemp-derived CBD products we are developing will target consumer
preference towards natural health & wellness products."
Christophe
de Villeplee, IFF's SVP Global Consumer Fragrance added, "With health
& wellness a key pillar of IFF's strategy, we believe this new partnership
will greatly benefit from IFF-LMR's global expertise and leadership in
naturals.”
Whether
through strategic partnerships and JV’s for companies like Real Brands or
having a massive in-house infrastructure like some of the leaders, having quick
access for new product innovation and speed to market is becoming increasingly
important when it comes to brand building and as this market is still far from
full maturation, there is currently an abundance of brand opportunity in the
future.
With
professional athlete Scott Piercy, World-renowned PGA Tour Professional Golf
Pro signing on as brand ambassador for Real Brands and music icon Snoop Dog
lending his name to new products, the industry is ramping up for a real battle
of the brands.
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our news
alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto
Corner , Play by Play
sports and stock news column, Investor
Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure: this news article featuring
RLBD is a paid for news release on Investorideas.com – third party (two
thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800-665-0411
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Subscribe to:
Comments (Atom)
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 481 (CSE: $PRMO.C) (TSXV: $ENW.V) (CSE: $IPOT.C) (TSX: $FAF.TO) ... -
Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings : Pot Stock Canopy Growth Corporation (TSX: ...